FI971124A0 - Metod foer diagnostisering av magcancer - Google Patents

Metod foer diagnostisering av magcancer

Info

Publication number
FI971124A0
FI971124A0 FI971124A FI971124A FI971124A0 FI 971124 A0 FI971124 A0 FI 971124A0 FI 971124 A FI971124 A FI 971124A FI 971124 A FI971124 A FI 971124A FI 971124 A0 FI971124 A0 FI 971124A0
Authority
FI
Finland
Prior art keywords
cox
magcancer
diagnosis
gastric cancer
intestinal type
Prior art date
Application number
FI971124A
Other languages
English (en)
Finnish (fi)
Inventor
Ari Ristimaeki
Matti Haerkoenen
Original Assignee
Locus Genex Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Locus Genex Oy filed Critical Locus Genex Oy
Priority to FI971124A priority Critical patent/FI971124A0/fi
Publication of FI971124A0 publication Critical patent/FI971124A0/fi
Priority to IL13159498A priority patent/IL131594A/en
Priority to BR9808378-3A priority patent/BR9808378A/pt
Priority to AU64041/98A priority patent/AU732228B2/en
Priority to CA002284048A priority patent/CA2284048A1/fr
Priority to US09/381,042 priority patent/US6416961B1/en
Priority to EP98909537A priority patent/EP0968421B1/fr
Priority to CN98803363A priority patent/CN1250523A/zh
Priority to NZ338068A priority patent/NZ338068A/xx
Priority to DE69825431T priority patent/DE69825431T2/de
Priority to AT98909537T priority patent/ATE272838T1/de
Priority to TR1999/02298T priority patent/TR199902298T2/xx
Priority to PT98909537T priority patent/PT968421E/pt
Priority to JP54017498A priority patent/JP2001519900A/ja
Priority to ES98909537T priority patent/ES2226105T3/es
Priority to KR1019997008388A priority patent/KR20000076291A/ko
Priority to RU99121656/14A priority patent/RU2204835C2/ru
Priority to PCT/FI1998/000238 priority patent/WO1998041864A1/fr
Priority to DK98909537T priority patent/DK0968421T3/da
Priority to NO994440A priority patent/NO994440L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI971124A 1997-03-18 1997-03-18 Metod foer diagnostisering av magcancer FI971124A0 (fi)

Priority Applications (20)

Application Number Priority Date Filing Date Title
FI971124A FI971124A0 (fi) 1997-03-18 1997-03-18 Metod foer diagnostisering av magcancer
DK98909537T DK0968421T3 (da) 1997-03-18 1998-03-18 Diagnose af tidlig gastrisk cancer
NZ338068A NZ338068A (en) 1997-03-18 1998-03-18 Diagnosis of early gastric cancer detecting cyclooxygenase-2 mRNA expression or Cox-2 protein overexpression
AT98909537T ATE272838T1 (de) 1997-03-18 1998-03-18 Diagnostik zur früherkennung von magenkrebs
AU64041/98A AU732228B2 (en) 1997-03-18 1998-03-18 Diagnosis of early gastric cancer
CA002284048A CA2284048A1 (fr) 1997-03-18 1998-03-18 Diagnostic precoce du cancer gastrique
US09/381,042 US6416961B1 (en) 1997-03-18 1998-03-18 Diagnosis of early gastric cancer
EP98909537A EP0968421B1 (fr) 1997-03-18 1998-03-18 Diagnostic precoce du cancer gastrique
CN98803363A CN1250523A (zh) 1997-03-18 1998-03-18 早期胃癌的诊断
IL13159498A IL131594A (en) 1997-03-18 1998-03-18 Method and diagnostic kit for early detection of gastrointestinal cancer
DE69825431T DE69825431T2 (de) 1997-03-18 1998-03-18 Diagnostik zur früherkennung von magenkrebs
BR9808378-3A BR9808378A (pt) 1997-03-18 1998-03-18 Método e meios para diagnosticar precocemente câncer gástrico
TR1999/02298T TR199902298T2 (xx) 1997-03-18 1998-03-18 Habislik �ncesi mide kanserinin te�hisi.
PT98909537T PT968421E (pt) 1997-03-18 1998-03-18 Diagnostico precoce do cancro gastrico
JP54017498A JP2001519900A (ja) 1997-03-18 1998-03-18 早期胃癌の診断法
ES98909537T ES2226105T3 (es) 1997-03-18 1998-03-18 Diagnostico de cancer precoz.
KR1019997008388A KR20000076291A (ko) 1997-03-18 1998-03-18 초기 위암의 진단방법
RU99121656/14A RU2204835C2 (ru) 1997-03-18 1998-03-18 Диагностика рака желудка на ранней стадии
PCT/FI1998/000238 WO1998041864A1 (fr) 1997-03-18 1998-03-18 Diagnostic precoce du cancer gastrique
NO994440A NO994440L (no) 1997-03-18 1999-09-13 Fremgangsmåte ved påvisning av tidlig magekreft

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI971124A FI971124A0 (fi) 1997-03-18 1997-03-18 Metod foer diagnostisering av magcancer

Publications (1)

Publication Number Publication Date
FI971124A0 true FI971124A0 (fi) 1997-03-18

Family

ID=8548414

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971124A FI971124A0 (fi) 1997-03-18 1997-03-18 Metod foer diagnostisering av magcancer

Country Status (20)

Country Link
US (1) US6416961B1 (fr)
EP (1) EP0968421B1 (fr)
JP (1) JP2001519900A (fr)
KR (1) KR20000076291A (fr)
CN (1) CN1250523A (fr)
AT (1) ATE272838T1 (fr)
AU (1) AU732228B2 (fr)
BR (1) BR9808378A (fr)
CA (1) CA2284048A1 (fr)
DE (1) DE69825431T2 (fr)
DK (1) DK0968421T3 (fr)
ES (1) ES2226105T3 (fr)
FI (1) FI971124A0 (fr)
IL (1) IL131594A (fr)
NO (1) NO994440L (fr)
NZ (1) NZ338068A (fr)
PT (1) PT968421E (fr)
RU (1) RU2204835C2 (fr)
TR (1) TR199902298T2 (fr)
WO (1) WO1998041864A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335193B1 (en) * 1999-04-15 2002-01-01 Padmanabhan P Nair Isolated colonocytes
WO2001051660A2 (fr) * 2000-01-14 2001-07-19 Vera Genics Ltd. Methode et kit de diagnostic de transformation neoplastique
EP2949762B1 (fr) * 2000-03-27 2018-05-09 Thomas Jefferson University Compositions pour le traitement de cellules cancereuses stomacales et oesophagiennes
US20020068307A1 (en) * 2000-03-30 2002-06-06 Jason Pluta Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
WO2003001183A2 (fr) * 2001-06-25 2003-01-03 Oncomedx, Inc. Methodes de detection et de surveillance du taux d'arn de cox-2 dans le plasma et le serum
WO2003060121A2 (fr) * 2001-12-21 2003-07-24 Diadexus, Inc. Compositions et procedes relatifs a des proteines et a des genes gastriques specifiques
KR100475642B1 (ko) * 2001-12-29 2005-03-10 한국생명공학연구원 암 발생 및 전이에 관여하는 단백질의 당쇄 변화를측정하여 암을 진단하는 방법 및 이를 이용한 진단킷트
WO2004007770A2 (fr) * 2002-07-10 2004-01-22 Oncotherapy Science, Inc. Procede de diagnostic de tumeurs gastriques de type intestinal
AU2003263607A1 (en) * 2002-10-25 2004-05-13 Japan As Represented By The President Of The University Of Tokyo Method for diagnosing diffuse-type gastric cancer
NZ544977A (en) * 2003-07-17 2009-07-31 Pacific Edge Biotechnology Ltd Cystatin SN ("CST1") as a marker for detection of gastric cancer
US20050014165A1 (en) * 2003-07-18 2005-01-20 California Pacific Medical Center Biomarker panel for colorectal cancer
US20050075543A1 (en) * 2003-10-03 2005-04-07 Calabrese Charles A. Method of anonymous medical testing and providing the patient with the test results
KR100645979B1 (ko) * 2004-08-09 2006-11-15 한국생명공학연구원 위암 유전자 마커 및 이를 이용한 위암 진단킷트
US20080032943A1 (en) * 2005-11-04 2008-02-07 Johji Inazawa Method for detecting cancer and a method for suppressing cancer
RU2613139C1 (ru) * 2015-10-12 2017-03-15 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ дифференциальной диагностики рака желудка различных гистологических типов
RU2613300C1 (ru) * 2015-11-10 2017-03-15 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ диагностики низко дифференцированного нейроэндокринного рака желудка
RU2642989C1 (ru) * 2016-12-19 2018-01-29 федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский политехнический университет Петра Великого" (ФГАОУ ВО "СПбПУ") Способ диагностики онкологических заболеваний
CN109387635A (zh) * 2018-11-07 2019-02-26 国家纳米科学中心 基于热泳细胞外囊泡检测的胃癌检测系统及方法
RU2743221C1 (ru) * 2020-10-12 2021-02-16 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации Способ определения типа рака желудка по классификации lauren методом компьютерной томографии

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459239A (en) 1994-01-24 1995-10-17 Merck Frosst Canada Inc. Peptide sequences and antipeptide antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2 proteins

Also Published As

Publication number Publication date
CA2284048A1 (fr) 1998-09-24
EP0968421B1 (fr) 2004-08-04
CN1250523A (zh) 2000-04-12
IL131594A0 (en) 2001-01-28
NO994440D0 (no) 1999-09-13
KR20000076291A (ko) 2000-12-26
IL131594A (en) 2004-02-19
ATE272838T1 (de) 2004-08-15
EP0968421A1 (fr) 2000-01-05
AU6404198A (en) 1998-10-12
NO994440L (no) 1999-11-18
WO1998041864A1 (fr) 1998-09-24
TR199902298T2 (xx) 2000-01-21
DK0968421T3 (da) 2004-12-06
DE69825431D1 (de) 2004-09-09
AU732228B2 (en) 2001-04-12
NZ338068A (en) 2001-03-30
RU2204835C2 (ru) 2003-05-20
PT968421E (pt) 2004-10-29
JP2001519900A (ja) 2001-10-23
BR9808378A (pt) 2000-05-23
ES2226105T3 (es) 2005-03-16
US6416961B1 (en) 2002-07-09
DE69825431T2 (de) 2005-07-28

Similar Documents

Publication Publication Date Title
FI971124A0 (fi) Metod foer diagnostisering av magcancer
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DK0667920T3 (da) Fremgangsmåder til påvisning af prostatacancermetastase
JP2002541481A5 (fr)
ATE364089T1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
WO2005096937A3 (fr) Capsule et procede pour traiter ou diagnostiquer des etats ou des maladies du tractus intestinal
WO2001075454A3 (fr) Molecules d'acides nucleiques, polypeptides et leurs utilisations pour diagnostic et le traitement de la maladie d'alzheimer notamment
WO2000056352A3 (fr) Reactifs et procedes utiles pour detecter les maladies de la prostate
HK1086331A1 (en) Compounds and methods for detection of carcinomas and their precursor lesions
DE69535107D1 (de) Detektion von änderungen von tumor-suppressor genen zur diagnose von krebs
WO2003001183A3 (fr) Methodes de detection et de surveillance du taux d'arn de cox-2 dans le plasma et le serum
Liebes et al. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
ATE323176T1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
WO2002004952A3 (fr) Methodes diagnostiques et therapeutiques basees sur la molecule d'adhesion l1 pour le traitement d'une tumeur de l'ovaire ou de l'endometre
WO2001063293A8 (fr) Proteines et genes et leur utilisation dans le diagnostic et le traitement de la schizophrenie
WO2004084804A3 (fr) Methodes, compositions et trousses pour la detection et pour la surveillance d'un cancer du poumon
Rinderknecht et al. Abnormalities in pancreatic secretory profiles of patients with cancer of the pancreas
WO2001004343A3 (fr) Procede permettant d'etablir un pronostic pour des patients atteints d'un cancer, par mesure des niveaux d'expression de la proteine bag
WO2004002294B1 (fr) Marqueur plasmatique ou serique et procede pour detecter un cancer
WO1998021365A3 (fr) Procede de detection du cancer de la prostate metastatique
WO2001065262A3 (fr) Reactifs et methodes de detection des pathologies mammaires
DE69939623D1 (de) Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)
AU2001285157A1 (en) 5t4 rna in plasma and serum as a marker for neoplastic disease
RU94003765A (ru) Способ прогнозирования рецидивов полипообразования и рака толстой кишки после полипэктомии
WO2002081656A3 (fr) Potentiel diagnostique ameliore de cellules exprimant l'antigene specifique de la prostate

Legal Events

Date Code Title Description
FD Application lapsed